Authors:
Rimsza, LM
Larson, RS
Winter, SS
Foucar, K
Chong, YY
Garner, KW
Leith, CP
Citation: Lm. Rimsza et al., Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features, AM J CLIN P, 114(1), 2000, pp. 66-75
Citation: Ds. Viswanatha et al., Elastic mantle cell leukemia: An unusual presentation of blastic mantle cell lymphoma, MOD PATHOL, 13(7), 2000, pp. 825-833
Authors:
Chauncey, TR
Rankin, C
Anderson, JE
Chen, IM
Kopecky, KJ
Godwin, JE
Kalaycio, ME
Moore, DF
Shurafa, MS
Petersdorf, SH
Kraut, EH
Leith, CP
Head, DR
Luthardt, FW
Willman, CL
Appelbaum, FR
Citation: Tr. Chauncey et al., A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and theMDR modulator PSC 833: a Southwest Oncology Group study 9617, LEUK RES, 24(7), 2000, pp. 567-574
Authors:
Leith, CP
Kopecky, KJ
Chen, IM
Eijdems, L
Slovak, ML
McConnell, TS
Head, DR
Weick, J
Grever, MR
Appelbaum, FR
Willman, CL
Citation: Cp. Leith et al., Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study, BLOOD, 94(3), 1999, pp. 1086-1099